Exelixis, Inc. (EXEL)
68.24
-0.26
(-0.38%)
USD |
NASDAQ |
Nov 18, 16:00
67.65
-0.59
(-0.86%)
After-Hours: 19:42
Exelixis Total Return Level : 68.50 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 68.50 |
| November 16, 2026 | 67.10 |
| November 13, 2026 | 69.00 |
| November 12, 2026 | 69.84 |
| November 11, 2026 | 70.70 |
| November 10, 2026 | 70.58 |
| November 09, 2026 | 71.74 |
| November 06, 2026 | 69.57 |
| November 05, 2026 | 68.71 |
| November 04, 2026 | 72.75 |
| November 03, 2026 | 72.31 |
| November 02, 2026 | 70.13 |
| October 30, 2026 | 69.39 |
| October 29, 2026 | 66.20 |
| October 28, 2026 | 66.28 |
| October 27, 2026 | 65.35 |
| October 26, 2026 | 65.11 |
| October 23, 2026 | 64.53 |
| October 22, 2026 | 65.31 |
| October 21, 2026 | 64.58 |
| October 20, 2026 | 64.39 |
| October 19, 2026 | 62.68 |
| October 16, 2026 | 62.23 |
| October 15, 2026 | 62.83 |
| October 14, 2026 | 60.99 |
| Date | Value |
|---|---|
| October 13, 2026 | 59.51 |
| October 12, 2026 | 59.82 |
| October 09, 2026 | 59.86 |
| October 08, 2026 | 59.02 |
| October 07, 2026 | 58.44 |
| October 06, 2026 | 58.33 |
| October 05, 2026 | 58.85 |
| October 02, 2026 | 58.39 |
| October 01, 2026 | 57.94 |
| September 30, 2026 | 58.41 |
| September 29, 2026 | 58.65 |
| September 28, 2026 | 58.37 |
| September 25, 2026 | 58.16 |
| September 24, 2026 | 57.95 |
| September 23, 2026 | 56.73 |
| September 22, 2026 | 58.15 |
| September 21, 2026 | 57.22 |
| September 18, 2026 | 58.36 |
| September 17, 2026 | 58.49 |
| September 16, 2026 | 56.78 |
| September 15, 2026 | 56.90 |
| September 14, 2026 | 56.21 |
| September 11, 2026 | 56.12 |
| September 10, 2026 | 57.43 |
| September 09, 2026 | 58.33 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| BioMarin Pharmaceutical, Inc. | 58.51 |
| Alnylam Pharmaceuticals, Inc. | 156.50 |
| Arrowhead Pharmaceuticals, Inc. | 42.99 |
| Cytokinetics, Inc. | 51.65 |
| Gilead Sciences, Inc. | 249.53 |